Cargando…

The magnitude of precancerous cervical lesions and its associated factors among women screened for cervical cancer at a referral center in southern Ethiopia, 2021: a cross-sectional study

BACKGROUND: Cervical cancer is the most prevalent gynecologic cancer in women and the second leading cause of cancer death worldwide. Africa's southern, eastern, and western regions have the highest rates of cervical cancer. Cervical cancer is treatable and curable when detected early, but it i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tenkir, Lidiya, Mamuye, Abyalew, Jemebere, Wegene, Yeheyis, Tomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469314/
https://www.ncbi.nlm.nih.gov/pubmed/37664421
http://dx.doi.org/10.3389/fgwh.2023.1187916
_version_ 1785099413687894016
author Tenkir, Lidiya
Mamuye, Abyalew
Jemebere, Wegene
Yeheyis, Tomas
author_facet Tenkir, Lidiya
Mamuye, Abyalew
Jemebere, Wegene
Yeheyis, Tomas
author_sort Tenkir, Lidiya
collection PubMed
description BACKGROUND: Cervical cancer is the most prevalent gynecologic cancer in women and the second leading cause of cancer death worldwide. Africa's southern, eastern, and western regions have the highest rates of cervical cancer. Cervical cancer is treatable and curable when detected early, but it is nonetheless fatal in low- and middle-income (LMIC) nations where screening and early detection are not widely accessible. OBJECTIVE: The objective of this study is to assess the magnitude of precancerous cervical lesions and their associated factor among women screened for cervical cancer at a referral center in southern Ethiopia, in 2021. METHODS: A retrospective institution-based cross-sectional study was conducted from February 21 to April 14, 2022, among randomly selected 372 records of women screened for cervical cancer at Hawassa University Specialized Hospital. Data were extracted from clients' charts using a data extraction checklist. Statistical Package for Social Sciences version 26 and logistic regression analysis were applied to determine the association between dependent and independent variables, and significance was declared at p-value <0.05. RESULTS: The magnitude of abnormal cervical dysplasia in this study was 18.3% of which 14% were precancerous cervical lesions and 4.3% were cervical cancer. Early coitarche: Adjusted odds ratio (AOR) = 5.6 [95% (confidence interval) CI = 1.87–16.78], having more than one sexual partner: AOR = 2.6 [95% CI = 1.2–5.68], being HIV positive: AOR = 3.56 [95% CI = 1.53–8.29], and having sexually transmitted infections: AOR = 4.64 [95% CI = 2.08–10.35] were independent predictors of precancerous cervical lesions. CONCLUSION: The magnitude of precancerous cervical lesions in the study setting is 18% and the magnitude of cervical cancer is 14%, which is higher than the pooled prevalence of precancerous cervical lesions in Ethiopia. Having multiple sexual partners, being HIV positive, having sexual intercourse before 21 years, and new STI diagnosis was independently associated with abnormal precancerous cervical lesions.
format Online
Article
Text
id pubmed-10469314
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104693142023-09-01 The magnitude of precancerous cervical lesions and its associated factors among women screened for cervical cancer at a referral center in southern Ethiopia, 2021: a cross-sectional study Tenkir, Lidiya Mamuye, Abyalew Jemebere, Wegene Yeheyis, Tomas Front Glob Womens Health Global Women's Health BACKGROUND: Cervical cancer is the most prevalent gynecologic cancer in women and the second leading cause of cancer death worldwide. Africa's southern, eastern, and western regions have the highest rates of cervical cancer. Cervical cancer is treatable and curable when detected early, but it is nonetheless fatal in low- and middle-income (LMIC) nations where screening and early detection are not widely accessible. OBJECTIVE: The objective of this study is to assess the magnitude of precancerous cervical lesions and their associated factor among women screened for cervical cancer at a referral center in southern Ethiopia, in 2021. METHODS: A retrospective institution-based cross-sectional study was conducted from February 21 to April 14, 2022, among randomly selected 372 records of women screened for cervical cancer at Hawassa University Specialized Hospital. Data were extracted from clients' charts using a data extraction checklist. Statistical Package for Social Sciences version 26 and logistic regression analysis were applied to determine the association between dependent and independent variables, and significance was declared at p-value <0.05. RESULTS: The magnitude of abnormal cervical dysplasia in this study was 18.3% of which 14% were precancerous cervical lesions and 4.3% were cervical cancer. Early coitarche: Adjusted odds ratio (AOR) = 5.6 [95% (confidence interval) CI = 1.87–16.78], having more than one sexual partner: AOR = 2.6 [95% CI = 1.2–5.68], being HIV positive: AOR = 3.56 [95% CI = 1.53–8.29], and having sexually transmitted infections: AOR = 4.64 [95% CI = 2.08–10.35] were independent predictors of precancerous cervical lesions. CONCLUSION: The magnitude of precancerous cervical lesions in the study setting is 18% and the magnitude of cervical cancer is 14%, which is higher than the pooled prevalence of precancerous cervical lesions in Ethiopia. Having multiple sexual partners, being HIV positive, having sexual intercourse before 21 years, and new STI diagnosis was independently associated with abnormal precancerous cervical lesions. Frontiers Media S.A. 2023-08-16 /pmc/articles/PMC10469314/ /pubmed/37664421 http://dx.doi.org/10.3389/fgwh.2023.1187916 Text en © 2023 Tenkir, Mamuye, Jemebere and Yeheyis. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Global Women's Health
Tenkir, Lidiya
Mamuye, Abyalew
Jemebere, Wegene
Yeheyis, Tomas
The magnitude of precancerous cervical lesions and its associated factors among women screened for cervical cancer at a referral center in southern Ethiopia, 2021: a cross-sectional study
title The magnitude of precancerous cervical lesions and its associated factors among women screened for cervical cancer at a referral center in southern Ethiopia, 2021: a cross-sectional study
title_full The magnitude of precancerous cervical lesions and its associated factors among women screened for cervical cancer at a referral center in southern Ethiopia, 2021: a cross-sectional study
title_fullStr The magnitude of precancerous cervical lesions and its associated factors among women screened for cervical cancer at a referral center in southern Ethiopia, 2021: a cross-sectional study
title_full_unstemmed The magnitude of precancerous cervical lesions and its associated factors among women screened for cervical cancer at a referral center in southern Ethiopia, 2021: a cross-sectional study
title_short The magnitude of precancerous cervical lesions and its associated factors among women screened for cervical cancer at a referral center in southern Ethiopia, 2021: a cross-sectional study
title_sort magnitude of precancerous cervical lesions and its associated factors among women screened for cervical cancer at a referral center in southern ethiopia, 2021: a cross-sectional study
topic Global Women's Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469314/
https://www.ncbi.nlm.nih.gov/pubmed/37664421
http://dx.doi.org/10.3389/fgwh.2023.1187916
work_keys_str_mv AT tenkirlidiya themagnitudeofprecancerouscervicallesionsanditsassociatedfactorsamongwomenscreenedforcervicalcanceratareferralcenterinsouthernethiopia2021acrosssectionalstudy
AT mamuyeabyalew themagnitudeofprecancerouscervicallesionsanditsassociatedfactorsamongwomenscreenedforcervicalcanceratareferralcenterinsouthernethiopia2021acrosssectionalstudy
AT jemeberewegene themagnitudeofprecancerouscervicallesionsanditsassociatedfactorsamongwomenscreenedforcervicalcanceratareferralcenterinsouthernethiopia2021acrosssectionalstudy
AT yeheyistomas themagnitudeofprecancerouscervicallesionsanditsassociatedfactorsamongwomenscreenedforcervicalcanceratareferralcenterinsouthernethiopia2021acrosssectionalstudy
AT tenkirlidiya magnitudeofprecancerouscervicallesionsanditsassociatedfactorsamongwomenscreenedforcervicalcanceratareferralcenterinsouthernethiopia2021acrosssectionalstudy
AT mamuyeabyalew magnitudeofprecancerouscervicallesionsanditsassociatedfactorsamongwomenscreenedforcervicalcanceratareferralcenterinsouthernethiopia2021acrosssectionalstudy
AT jemeberewegene magnitudeofprecancerouscervicallesionsanditsassociatedfactorsamongwomenscreenedforcervicalcanceratareferralcenterinsouthernethiopia2021acrosssectionalstudy
AT yeheyistomas magnitudeofprecancerouscervicallesionsanditsassociatedfactorsamongwomenscreenedforcervicalcanceratareferralcenterinsouthernethiopia2021acrosssectionalstudy